In this work, a genetic study of a cohort of patients diagnosed and treated of BC (the population is described below in Materials and Methods), along with a descriptive analysis of relevant clinical variables, the scrutiny of the variants identified, and a cosegregation evaluation have been carried out to identify the prevalence of missense variants in the CHEK2 gene. The gene discussed is CHEK2; the disease is breast cancer.